SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 117 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $1,294,000 | -87.0% | 159,122 | -87.4% | 0.05% | -87.2% |
| Q1 2014 | $9,921,000 | -52.5% | 1,265,375 | -46.4% | 0.40% | -62.6% |
| Q4 2013 | $20,898,000 | -17.7% | 2,361,405 | -22.1% | 1.08% | -8.4% |
| Q3 2013 | $25,406,000 | +10619.8% | 3,031,750 | +9448.8% | 1.18% | +10645.5% |
| Q2 2013 | $237,000 | – | 31,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,829,878 | $97,942,000 | 5.27% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $3,863,000 | 1.84% |
| Sonora Investment Management, LLC | 744,714 | $12,511,000 | 1.73% |
| ASHFORD CAPITAL MANAGEMENT INC | 537,644 | $9,032,000 | 1.09% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 57,885 | $972,000 | 0.77% |
| Kazazian Asset Management, LLC | 37,590 | $632,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $8,400,000 | 0.55% |
| J. Goldman & Co LP | 409,426 | $6,878,000 | 0.48% |
| J. Goldman & Co LP | 393,000 | $6,602,000 | 0.46% |
| Orbimed Advisors | 2,265,500 | $38,060,000 | 0.46% |